Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;24(11):730–734. doi: 10.1002/clc.4960241108

Possible ethnic differences in plasma homocysteine levels associated with coronary artery disease between south asian and east asian immigrants

Manohara P J Senaratne 1,, Karen Macdonald 1, Dilshana De Silva 1
PMCID: PMC6654872  PMID: 11714131

Abstract

Background: Hyperhomocysteinemia has been identified as a risk factor for coronary artery disease (CAD). South Asians appear to have a high incidence of CAD, while East Asians have a very low incidence.

Hypothesis: The present study was undertaken because the relative association of plasma homocysteine levels (PH) with CAD in South Asians (SA = Indian, Pakistani, Sri Lankan) and East Asians (EA = Chinese, Japanese) is not known.

Methods: Fasting PH were drawn on all patients with CAD of SA (age 62.4 ± 1.1 years, 72 men, 14 women) and EA (age 61.8 ± 3.0 years, 13 men, 4 women) descent. These were compared with PH available from Caucasian (CA) patients (age 61.1 ± 1.1 years, 89 men, 17 women) with CAD.

Results: The PH in SA, EA, and CA patients were 11.0 ± 0.5, 7.6 ± 0.5, and 10.8 ± 0.6 μmol/l, respectively (p < 0.001 between EA and SA/CA). Percentages of SA, EA, and CA with elevated PH (> 12.0 μmol/l) were 33.7, 5.9, and 28.2%, respectively. There were no significant differences in the lipid subtractions between the SA and EA group. History of smoking was significantly higher in the EA (52.9 vs. 26.2%), while hypertension and diabetes mellitus had similar prevalences.

Conclusion: Significant differences in PH of SA versus EA patients with CAD exist. The relative contribution of homocysteine in the development of CAD appears to be less in EA immigrants. In contrast, the association between CAD and PH in SA immigrants appears to be similar to that of Caucasians.

Keywords: homocysteine, coronary artery disease, ethnicity, Asians, risk factors

Full Text

The Full Text of this article is available as a PDF (614.7 KB).

References

  • 1. Farmer JA, Gotto AM Jr: Dyslipidemia and other risk factors for coronary artery disease In Heart Disease: A Textbook of Cardiovascular Medicine, 5th ed., p. 1126–1160 (Ed. Braunwald E.). Philadelphia: WB Saunders, 1997. [Google Scholar]
  • 2. Steinberg D: Antioxidant vitamins and coronary heart disease. N Engl J Med 993; 28: 1487–1489 [DOI] [PubMed] [Google Scholar]
  • 3. Ascherio A, Willett WC: Are body iron stores related to the risk of coronary heart disease? N Engl J Med 1994; 330: 1152–1154 [DOI] [PubMed] [Google Scholar]
  • 4. Mayer EL, Jacobsen DW, Robinson K: Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517–527 [DOI] [PubMed] [Google Scholar]
  • 5. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042–1050 [DOI] [PubMed] [Google Scholar]
  • 6. Graham JM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma‐Reis R, Boers GHJ, Sheahan RG, Israelsson B, Uiterwall CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot‐Roulaud FM, Tan KS, Higgins I, Garcon D, Medrano MJ, Candito M, Evans AE, Andria G: Plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 1997; 277: 1775–1781 [DOI] [PubMed] [Google Scholar]
  • 7. Dhawan J: Coronary heart disease risks in Asian Indians. Curr Opin Lipidol 1996; 7: 196–198 [DOI] [PubMed] [Google Scholar]
  • 8. Enas EA, Mehta J: Malignant coronary artery disease in young Asian Indians: Thoughts on pathogenesis, prevention and therapy. Clin Cardiol 1995; 18: 131–135 [DOI] [PubMed] [Google Scholar]
  • 9. Jolly KS, Pais P, Rihal CS: Coronary artery disease among South Asians: Identification of a high risk population. Can J Cardiol 1996; 12: 569–571 [PubMed] [Google Scholar]
  • 10. Vardan S, Mookherjee S, Vardan S, Sinha AKN: Special features of coronary heart disease in people of the Indian sub‐continent. Int Heart J 1995; 47; 399–407 [PubMed] [Google Scholar]
  • 11. Trombold JC, Moellering RC, Kagan A: Epidemiological aspects of coronary heart disease and cerebrovascular disease: The Honolulu Heart Program. Hawaii Med J 1966; 25: 231–234 [PubMed] [Google Scholar]
  • 12. Vander Griend R, Haas FJCM, Biesma DH, Duran M, Meuwissen OJ, Banja JD: Combination of low‐dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives. Atherosclerosis 1999; 143: 177–183 [DOI] [PubMed] [Google Scholar]
  • 13. Gupta SP, Malhotra KC: Urban‐rural trends in the epidemiology of coronary heart disease. J Assoc Physicians India 1975; 23: 883–887 [PubMed] [Google Scholar]
  • 14. Sarvotham SG, Berry JN: Prevalence of coronary heart disease in an urban population in Northern India. Circulation 1968; 37: 939–953 [DOI] [PubMed] [Google Scholar]
  • 15. Enas EA, Yusuf S, Sharma S: Coronary artery disease in South Asians. Indian Heart J 1998; 50: 105–113 [PubMed] [Google Scholar]
  • 16. Senaratne MPJ, Irwin ME, Shaben S, Griffiths J, Nagendran J, Kasza L, Gulamhusein S, Haughian M: Feasibility of direct discharge from the coronary/intermediate care unit after acute myocardial infarction. J Am Coll Cardiol 1999; 33: 1040–1046 [DOI] [PubMed] [Google Scholar]
  • 17. Housing, Family and Social Statistics . 1996. Census. Statistics Canada.
  • 18. Araki A, Sako Y, Ito H: Plasma homocysteine concentrations in Japanese patients with non‐insulin‐dependent diabetes mellitus: Effect of parental methylcobalamin treatment. Atherosclerosis 1993; 103: 149–157 [DOI] [PubMed] [Google Scholar]
  • 19. Alfthan G, Aro A, Gey KF: Plasma homocysteine and cardiovascular disease mortality. Lancet 1997; 349; 397 [DOI] [PubMed] [Google Scholar]
  • 20. Anand S, Yusuf S, Vukson V, Devanesen S, Montaque P, Kelemen L, Yi Q, Lonn E, Gerstein H, McQueen M, Teo K: Differences in cardiovascular disease between ethnic groups are not explained by conventional risk factors of atherosclerosis. The study of health assessment and risk in ethnic groups (abstr). J Am Coll Cardiol 2000: 35 (suppl A); 283–284 [Google Scholar]
  • 21. Lolin YI, Sanderson JE, Cheng SK, Chan CF, Pang CP, Woo KS, Masarei JR: Hyperhomocysteinaemia and premature coronary artery disease in the Chinese. Heart 1996; 76: 117–122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Malinow MR, Bostom AG, Krauss RM: Homocysteine, diet, and cardiovascular diseases. Circulation 1999: 99; 178–182 [DOI] [PubMed] [Google Scholar]
  • 23. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999: 340; 1449–1454 [DOI] [PubMed] [Google Scholar]
  • 24. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995: 10; 111–113 [DOI] [PubMed] [Google Scholar]
  • 25. Arruda VR, von Zuben PM, Chiaparini LC, Annichino‐Bizzacchi JM, Costa FF: The mutation Ala677 → Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997: 77; 818–821 [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES